These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28711708)

  • 1. Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.
    Ghanim H; Green K; Abuaysheh S; Patel R; Batra M; Chaudhuri A; Makdissi A; Kuhadiya ND; Dandona P
    Atherosclerosis; 2017 Aug; 263():278-286. PubMed ID: 28711708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe + statin: insufficient benefit.
    Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Visseren FL
    Atherosclerosis; 2009 Jan; 202(1):216-24. PubMed ID: 18533158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.
    Westerink J; Deanfield JE; Imholz BP; Spiering W; Basart DC; Coll B; Kastelein JJ; Visseren FL
    Atherosclerosis; 2013 Mar; 227(1):118-24. PubMed ID: 23261174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe: rescued by randomization (clinical and mendelian).
    McPherson R; Hegele RA
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):e13-5. PubMed ID: 25550209
    [No Abstract]   [Full Text] [Related]  

  • 8. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
    Storey BC; Staplin N; Haynes R; Reith C; Emberson J; Herrington WG; Wheeler DC; Walker R; Fellström B; Wanner C; Landray MJ; Baigent C;
    Kidney Int; 2018 Apr; 93(4):1000-1007. PubMed ID: 29146277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe.
    Rudofsky G; Reismann P; Groener JB; Djuric Z; Fleming T; Metzner C; Grafe IA; Bierhaus A; Nawroth PP
    Atherosclerosis; 2012 Jul; 223(1):190-6. PubMed ID: 22633472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients.
    Cerda A; Rodrigues AC; Alves C; Genvigir FD; Fajardo CM; Dorea EL; Gusukuma MC; Pinto GA; Hirata MH; Hirata RD
    Cardiovasc Ther; 2015 Aug; 33(4):168-76. PubMed ID: 25903419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients.
    Ahmed O; Littmann K; Gustafsson U; Pramfalk C; Öörni K; Larsson L; Minniti ME; Sahlin S; Camejo G; Parini P; Eriksson M
    J Am Heart Assoc; 2018 Dec; 7(24):e009876. PubMed ID: 30561264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein.
    Berthold HK; Berneis K; Mantzoros CS; Krone W; Gouni-Berthold I
    Scand Cardiovasc J Suppl; 2013 Feb; 47(1):20-7. PubMed ID: 23013513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia.
    Hernandez-Mijares A; Bañuls C; Rovira-Llopis S; Diaz-Morales N; Escribano-Lopez I; de Pablo C; Alvarez A; Veses S; Rocha M; Victor VM
    Atherosclerosis; 2016 Apr; 247():40-7. PubMed ID: 26868507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study.
    Lee YH; Hong N; Lee CJ; Park SH; Lee BW; Cha BS; Kang ES
    Sci Rep; 2018 Aug; 8(1):11925. PubMed ID: 30093717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.
    Zubaid M; Shakir DK; Bazargani N; Binbrek A; Gopal R; Al-Tamimi O; Bakir S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):688-93. PubMed ID: 18545068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.